Onkure Therapeutics Inc (OKUR)

May 22, 2026

Survey finds most Boulder residents satisfied with quality of life - BizWest

May 22, 2026

May 21, 2026

OnKure Therapeutics (OKUR) Surges 14% Amid Renewed Investor InterestMerger Arbitrage - Newser

May 21, 2026

May 21, 2026

OnKure Therapeutics (OKUR) Q1 2026 Earnings Miss: EPS $-1.11 vs $-0.76 ExpectedReal Trader Insights - Newser

May 21, 2026

May 15, 2026

ADAR1 entities and Daniel Schneeberger report 6.0% of OnKure (NASDAQ: OKUR) - Stock Titan

May 15, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

The long term thesis for OnKure Therapeutics (OKUR) in plain sight (Breakdown Watch) 2026-05-11Social Momentum Signals - newser.com

May 11, 2026

May 10, 2026

OnKure Therapeutics (OKUR) Receives a Rating Update from a Top Analyst - The Globe and Mail

May 10, 2026

May 07, 2026

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), OnKure Therapeutics (OKUR) and Cogent Biosciences (COGT) - The Globe and Mail

May 07, 2026

May 07, 2026

OnKure Therapeutics downgraded to Hold from Buy at JonesResearch - TipRanks

May 07, 2026

May 06, 2026

OnKure Therapeutics war chest nears $200M following spring stock sale - BizWest

May 06, 2026

May 06, 2026

OnKure Buy Rating Reiterated as Analyst Backs Pipeline Refocus, Strong Cash Position and Maintains $16 Price Target - TipRanks

May 06, 2026

May 05, 2026

Onkure Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 05, 2026

May 05, 2026

[10-Q] OnKure Therapeutics, Inc. Quarterly Earnings Report - Stock Titan

May 05, 2026

May 05, 2026

OnKure (Nasdaq: OKUR) lifts cash to $192.1 million after raise - Stock Titan

May 05, 2026

May 05, 2026

OnKure bets on 2 PI3K drugs for breast cancer and vascular anomalies - Stock Titan

May 05, 2026

May 05, 2026

OnKure Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 05, 2026

May 05, 2026

OnKure Therapeutics Reports First Quarter 2026 Financial Results - marketscreener.com

May 05, 2026

May 05, 2026

[EFFECT] OnKure Therapeutics, Inc. SEC Filing - Stock Titan

May 05, 2026

May 01, 2026

Aclarion reports cash runway to ops into late 2027 - BizWest

May 01, 2026

Apr 30, 2026

What date does OnKure Therapeutics, Inc.'s (OKUR) report EarningsEarnings Calendar & Announcement - Zacks Investment Research

Apr 30, 2026

Apr 28, 2026

OnKure Therapeutics (OKUR) price target decreased by 15.13% to 20.60 - MSN

Apr 28, 2026

Apr 28, 2026

OnKure Therapeutics (OKUR) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Apr 28, 2026

Apr 27, 2026

OnKure Therapeutics prices $150M oversubscribed private placement - MSN

Apr 27, 2026

Apr 27, 2026

What top holdings OnKure Therapeutics (OKUR)? (Smart Money Active) 2026-04-27Earnings Beat Stocks - Newser

Apr 27, 2026

Apr 27, 2026

OKUR (OnKure Therapeutics) reports narrower Q4 2025 loss than estimates, shares drop 2.04 percent in trading.Revenue Growth Rate - Newser

Apr 27, 2026

Apr 26, 2026

Short Interest in OnKure Therapeutics, Inc. (NASDAQ:OKUR) Drops By 57.6% - MarketBeat

Apr 26, 2026

Apr 25, 2026

OnKure Therapeutics (OKUR) Price Target Decreased by 10.00% to 27.54 - MSN

Apr 25, 2026

Apr 24, 2026

OnKure Therapeutics (NASDAQ: OKUR) registers 36.1M shares for resale - Stock Titan

Apr 24, 2026

Apr 21, 2026

[DEF 14A] OnKure Therapeutics, Inc. Definitive Proxy Statement - Stock Titan

Apr 21, 2026

Apr 20, 2026

OnKure Therapeutics (OKUR) Stock Bollinger Bands (Risk Aversion) 2026-04-20Small Cap Breakout - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026

Apr 18, 2026

OnKure Therapeutics (OKUR) Stock Opening VWAP (Spikes) 2026-04-18Stock Distribution - Cổng thông tin điện tử tỉnh Lào Cai

Apr 18, 2026

Apr 16, 2026

Should I buy OnKure Therapeutics, Inc. (OKUR) - Zacks Investment Research

Apr 16, 2026

Apr 10, 2026

Short Interest in OnKure Therapeutics, Inc. (NASDAQ:OKUR) Increases By 1,958.6% - MarketBeat

Apr 10, 2026

Apr 10, 2026

Revenue Check: Whats the profit margin of OnKure Therapeutics Inc2026 Volume Leaders & Growth-Oriented Investment Plans - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Growth Recap: Is Vistra Corp gaining market shareQuarterly Trade Summary & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

OKUR SEC FilingsOnKure Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 08, 2026

Apr 07, 2026

Access Industries (OKUR) discloses 19.99% OnKure stake and board right - Stock Titan

Apr 07, 2026

Apr 07, 2026

StepStone affiliates report 2.66M shares in OnKure (NASDAQ: OKUR) - Stock Titan

Apr 07, 2026

Apr 07, 2026

RA Capital group reports 9.99% stake in OnKure (NASDAQ: OKUR) - Stock Titan

Apr 07, 2026

Apr 07, 2026

Trails Edge holds 6.0% of OnKure (NASDAQ: OKUR) after private placement - Stock Titan

Apr 07, 2026

Apr 07, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Apr 07, 2026

Apr 07, 2026

Trading Recap: Whats the profit margin of OnKure Therapeutics Inc2026 Biggest Moves & AI Driven Price Forecasts - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

LifeSci Capital Maintains OnKure Therapeutics(OKUR.US) With Buy Rating, Cuts Target Price to $16 - 富途牛牛

Apr 06, 2026